The expanded indication covers the device’s use as a bridging stent in fenestrated and branched aortic repair.

The balloon-expandable device can now be used as a bridge in fenestrated and branched endovascular aortic repair.

Gore & Associates announced FDA approval of an expanded indication for the company’s Viabahn VBX balloon expandable e ...

W. L. Gore & Associates' medical business (Gore) today announced U.S. Food and Drug Administration approval of an expanded indication for the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis (VBX ...

Gore today announced US Food and Drug Administration (FDA) approval of an expanded indication for the company's Viabahn VBX ...

The Advanced Research Projects Agency for Health (ARPA-H) has awarded Siemens Healthineers up to $31.1 million over five years to accelerate the development of autonomous, remote, endovascular ...

Endovascular thrombectomy is indicated for acute ischemic stroke due to a large vessel occlusion in the anterior circulation within 24 hours of the time last known to be well. The ORIENTAL-MeVO ...

W.L. Gore & Associates recently received approval from the Food and Drug Administration for a stent designed for the largest vein in the human body. The GORE VIABAHN FORTEGRA venous stent (FORTEGRA) ...

Post-thrombotic syndrome is common after deep-vein thrombosis and can cause severe symptoms involving the limbs that impair patients’ activity and quality of life. Endovascular therapy can eliminate ...

The latest round comes just over a year after its $42 million series B financing. (Getty Images) California-based medtech E2 (Endovascular Engineering) has raised $80 million in a series C funding ...

W. L. Gore & Associates has secured FDA approval for the GORE VIABAHN FORTEGRA Venous Stent — previously known as the GORE VIAFORT Vascular Stent — the first device for the treatment of deep venous ...